掌握肉毒毒素微滴注射：玫瑰痤疮与潮红的精准注射方案

目标: Managing rosacea erythema and flushing is clinically challenging. This lecture presents a standardized intradermal botulinum toxin type A protocol targeting neurogenic inflammation and vascular reactivity. We outline precise reconstitution ratios, 0.5–1cm grid mapping, and micro-droplet dosing tailored to the papillary dermis without affecting mimetic muscles. Data shows rapid reduction in flushing within 2–4 weeks, plus improved pore size and sebum control. This technique provides a safe, highly reproducible therapy for optimal skin quality. 介绍: Managing rosacea's persistent erythema and flushing requires targeting neurogenic inflammation and vascular reactivity. This lecture presents a standardized, highly reproducible protocol for intradermal botulinum toxin type A injection. By using precise reconstitution ratios, 0.5–1cm grid mapping, and micro-droplet dosing, this technique delivers toxin specifically to the papillary dermis while safely preserving mimetic muscle function. Clinical data demonstrates rapid flushing reduction within 2–4 weeks, alongside secondary benefits in pore size and sebum control. 材料 / 方法: Clinical preliminary study 结果: All patients showed improvement 总结: In conclusion, this standardized intradermal protocol provides a safe, reproducible solution for rosacea. By using precise grid mapping and micro-droplet dosing, we target vascular reactivity in the papillary dermis while preserving muscle function. Beyond rapidly reducing flushing and erythema within weeks, it refines pores and regulates sebum—making it an invaluable tool for optimizing skin quality and patient satisfaction